Видео 92
Просмотров 4 099

Panel Discussion: Catalyzing the Interface of Academia & Commercialization at Johns Hopkins

39:19

Sominair Pitch

8:25

Bispecific Autoantigen-T Cell Engagers (BAITE) Pitch

Bispecific Antibodies for Metastasis Pitch

9:40

Pitch It On! 2024 Event

JHTV hosted our 5th annual Pitch It On! competition which showcases Johns Hopkins University women inventors who present their technologies to coaches and a live audience.
If you missed it, you can watch the pitches now - SPOLIER ALERT - and join in congratulating the $20,000 prize winner: Mary Austin and her team from UrInControl! Their startup is developing an over-the-counter pessary for women with stress urinary incontinence (SUI).
This year, in honor of Women’s Entrepreneurship Day, Mary, Selena Shirkin, and Jordan Shuff pitched their innovations on November 19 to an audience of over 250 people. We were also joined by pitch coaches and JHU alums Gayathri Badrinath and Colleen Cutcliffe.

Видео

Panel Discussion: Catalyzing the Interface of Academia & Commercialization at Johns Hopkins

39:19

Panel Discussion: Catalyzing the Interface of Academia & Commercialization at Johns Hopkins

Просмотров 13721 день назад

Bill Nelson (Moderator), Liz Jaffee, Amir Zamani, and Isaac Kinde

8:25

Sominair Pitch

Просмотров 1221 день назад

Somnair is a non-invasive and cost-effective neurostimulation device for the treatment of obstructive sleep apnea. The device is custom-fitted, manufactured and delivered to patients in less than 10 days. Somnair comes with an app that provides usage tracking and disease alleviation monitoring for patients and clinicians Innovators: Anders Sideris, M.D., MSc. and Mitchell Turley

Bispecific Autoantigen-T Cell Engagers (BAITE) Pitch

10:39

Bispecific Autoantigen-T Cell Engagers (BAITE) Pitch

Просмотров 1421 день назад

First-in-class precision immunotherapies for autoimmune diseases. Selective depletion of autoreactive B cells with wide applicability across autoimmune and rheumatic diseases (e.g., antiphospholipid syndrome, lupus, rheumatoid arthritis). Normal immune cells are spared, eliminating risk of infection . Treatment of mild disease or even preclinical autoimmunity possible. Off-the-shelf, no need fo...

7:20

Biolinco Pitch

Просмотров 821 день назад

High-throughput screening platform utilizing DNA barcode technology to generate highly productive cell lines for more efficient manufacturing of biologic drugs. Screens 2500x more cells and reduce up to 50% of manufacturing costs. Innovator: Kent Rapp

7:43

OncoSwitch Pitch

Просмотров 3221 день назад

OncoSwitch has developed a proprietary nanoparticle technology platform to enable reprogramming of tumor cells to robustly activate both adaptive and innate immune responses. The nanoparticle technology platform is effective in treating cancer metastatases and can be used across a range of solid tumor cancers. Local administration triggers both local and systemic immunity while minimizing adver...

Bispecific Antibodies for Metastasis Pitch

9:40

Bispecific Antibodies for Metastasis Pitch

Просмотров 2721 день назад

Multifunctional antibody that specifically targets and blocks tumor metastasis as a novel cancer therapeutic. Innovator: Jamie Spangler, Ph.D.

Gene Therapy Targeting TDP-43 Mediated Diseases Pitch

7:59

Gene Therapy Targeting TDP-43 Mediated Diseases Pitch

Просмотров 621 день назад

Global rescue of TDP-43 loss-of-function resulting in restoration of splicing quality control and prevention of cell death. Novel biomarker to detect loss of TDP-43 function, enabling patient stratification and measurement of target engagement. Innovator: Philip Wong, Ph.D.

7:57

CurveAssure Pitch

Просмотров 7321 день назад

CurveAssure is an AI-driven musculoskeletal assessment platform that monitors functional response to treatment, tracks health over time, engages patients in their care, and reduces clinical documentation. Innovator: Evan Haas

5:53

Brahm Astra Pitch

Просмотров 2421 день назад

Brahm Astra develops highly selective precision cancer therapies through the power of epigenetic medicine and synthetic lethality. Brahm Astra is expanding the scope of epigenetic therapy to identify more selective and efficacious inhibitors. MBD2 inhibition is highly selective for neoplastic cells and can be used as standalone drugs or as components of induced synthetic lethality using Brahm A...

7:41

Bespoke Bone Pitch

Просмотров 1221 день назад

Capable of healing large, complex bone defects using point-of-care and off-the-shelf 3D-printed bone scaffolds. Innovators: Warren Grayson, Ph.D. and Tram Nguyen

7:42

Kubanda Cryotherapy Pitch

Просмотров 1521 день назад

Simple, point-of-care, minimally invasive treatment for lumps, bumps, and tumors - with a beachhead in the veterinary market. Innovators: Bailey Surtees and Clarisse Hu

7:55

Adventris Pharmaceuticals Pitch

Просмотров 1621 день назад

Adventris’ vaccine platform enables us to make “off the shelf" cancer vaccines targeting the most common oncogenes, for the treatment and prevention of cancer. Innovators: Jen Herbach and Mark Yarchoan, M.D.

Introduction to Pitch it On 2024 Presenters

1:45

Introduction to Pitch it On 2024 Presenters

Просмотров 2021 день назад

Hear directly from three female innovators who presented at Pitch It On! for the opportunity to win $20,000 to fund their technology. Johns Hopkins innovators Mary Austin, Selena Shirkin, and Jordan Shuff pitched virtually on Nov. 19 to a live audience and pitch coaches. Congratulations to our winner Mary Austin and team from urincontrol! The startup is developing an over-the-counter pessary fo...

1:45

Meet the Presenters of Pitch it On 2024

Просмотров 1921 день назад

Hear directly from three female innovators who will be presenting at Pitch It On! for the opportunity to win $20,000 to fund their technology. Johns Hopkins innovators Mary Austin, Selena Shirkin, and Jordan Shuff will pitch virtually on Nov. 19 at noon to a live audience and pitch coaches. Attend to vote for the most compelling pitch! RSVP at ventures.jhu.edu/pitchiton.